Korean J Nucl Med.
2000 Feb;34(1):22-29.
Comparison of Diagnostic and Post-therapy Radioiodine Scan in
Well-Differentiated Thyroid Cancer and the Clinical Outcome
Abstract
-
PURPOSE: We compared the first postoperative diagnostic and post-therapy scans of patients
who received therapeutic doses of I-131, to investigate the difference in clinical outcomes
between patients with concordant findings of diagnostic and post-therapy scans and patients
with discrepant (more lesions in post-therapy scan) findings.
MATERIALS AND METHODS
The first postoperative diagnostic and post-therapy radioiodine scans
of one hundred forty three patients with well differentiated thyroid carcinoma were reviewed.
Diagnostic scans were obtained following ingestion of 185 MBq of I-131 and post-therapy
scans were obtained after therapeutic dose of 3.7~9.3 GBq of I-131. Successful ablation
was defined as no radioiodine uptake on diagnostic radioiodine scan and normal range of
serum thyroglobulin level (<10 ng/ml) during serum TSH elevation.
RESULTS
Discrepant scan findings were noted in 25 (17.5%) patients. Twenty-two patients
(15.4%) showed more lesions in post-therapy scan and 3 patients (2.1%) showed stunning
effect. Nine (64.3%) of 14 patients with distant metastasis revealed metastatic lesion(s)
only on post-therapy scan. Stunning effect was considered as sublethal damage in 1 patient
and treatment by a diagnostic dose in 2 patients. Ablation was achieved in 52.4% (75/143)
of all patients. Ablation rate and mean cumulative radioiodine dose were not different
statistically between concordant and discrepant groups.
CONCLUSION
There were 17.5% difference between diagnostic and post-therapy
scan findings when using 185 MBq of I-131 as a diagnostic dose. However,
64.3% of distant metastases were revealed only on post-therapy scan.
Ablation rate and mean cumulative radioiodine dose were not different statistically
between concordant and discrepant groups. The stunning effect was considered as not only
sublethal damage but also treatment by a small diagnostic dose of radioiodine.